HuGE Literature Finder
Records
1
-
30
| Malignant Melanoma in Older Adults: Different Patient or Different Disease? Cureus 2023 3 15 (2): e34742. Sasson Daniel C, Smetona John T, Parsaei Yassmin, Papageorge Marianna, Ariyan Stephan, Olino Kelly, Clune Jam |
| Profile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients. Cancers 2023 2 15 (3): . Leite Ana Kober, Saito Kelly Cristina, Theodoro Thérèse Rachell, Pasini Fátima Solange, Camilo Luana Perrone, Rossetti Carlos Augusto, Cavalheiro Beatriz Godoi, Alves Venâncio Avancini Ferreira, Kowalski Luiz Paulo, Pinhal Maria Aparecida Silva, Kimura Edna Teruko, Matos Leandro Luon |
| Targeting BRAF V600E in metastatic colorectal cancer: where are we today? Ecancermedicalscience 2023 2 16 1489. Guerrero Rodrigo Motta, Labajos Veronica Arnao, Ballena Sophia Lozano, Macha Carlos Aliaga, Lezama Miguel Sotelo, Roman Cristian Pacheco, Beltran Paola Montenegro, Torrejon Alejandro Figuer |
| BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma. JCO precision oncology 2022 Sep 6 e2200018. van Not Olivier J, Blokx Willeke A M, van den Eertwegh Alfons J M, de Meza Melissa M, Haanen John B, Blank Christian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, de Groot Jan Willem B, Hospers Geke A P, Kapiteijn Ellen, Piersma Djura, van Rijn Rozemarijn S, Stevense-den Boer Marion, van der Veldt Astrid A M, Boers-Sonderen Marye J, Jansen Anne M L, Wouters Michel W J M, Suijkerbuijk Karijn P |
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| A Systematic Review and Meta-analysis on the Occurrence of Biomarker Mutation in Colorectal Cancer among the Asian Population. BioMed research international 2022 7 2022 5824183. Afolabi Hafeez, Md Salleh Salzihan, Zakaria Zaidi, Seng Ch'ng Ewe, Mohd Nafil Siti Norasikin Binti, Abdul Aziz Ahmad Aizat Bin, Wada Yusuf, Irekeola Ahm |
| Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF mutation-positive melanoma. Annals of oncology : official journal of the European Society for Medical Oncology 2022 2 33 (5): 544-555. Robert C, Lewis K D, Gutzmer R, Stroyakovskiy D, Gogas H, Protsenko S, Pereira R P, Eigentler T, Rutkowski P, Demidov L, Caro I, Forbes H, Shah K, Yan Y, Li H, McArthur G A, Ascierto P |
| BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer. The oncologist 2022 3 27 (3): 191-197. Tan Elaine, Whiting Junmin, Xie Hao, Imanirad Iman, Carballido Estrella, Felder Seth, Frakes Jessica, Mo Quanxing, Walko Christine, Permuth Jennifer B, Sommerer Katelyn, Kim Richard, Anaya Daniel A, Fleming Jason B, Sahin Ibrahim Hal |
| BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study. Cutis 2022 7 109 (5): 279-283. Harvey Jamison A, Lehman Julia S, Lohse Christine M, Chamberlain Alanna M, Markovic Svetomir N, Vachon Celine M, Brewer Jerry |
| Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC. JTO clinical and research reports 2022 5 3 (5): 100324. Johnson Bruce E, Baik Christina S, Mazieres Julien, Groen Harry J M, Melosky Barbara, Wolf Jürgen, Zadeh Vosta Kolaei Fatemeh Asad, Wu Wen-Hsing, Knoll Stefanie, Ktiouet Dawson Meryem, Johns Adam, Planchard Dav |
| Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. Kidney international 2022 11 103 (1): 177-186. Chazal Thibaud, Pegoraro Francesco, Manari Gaia, Bettiol Alessandra, Maniscalco Valerio, Gelain Elena, Charlotte Frédéric, Mazor Roei D, Renard-Penna Raphaele, Amoura Zahir, Cohen-Aubart Fleur, Haroche Julien, Izzedine Hassan, Vaglio Augus |
| Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer. Translational cancer research 2022 2 8 (3): 736-751. Kuang Xiao, Xiao Jian, Dai Long-Xia, Zhang Li-Hai, He Bi-X |
| Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer. Journal of oncology 2022 7 2022 6567998. Feng Fen, Sun Huake, Zhao Zhikun, Sun Chao, Zhao Yongtian, Lin Hanqing, Yang Jie, Xiao Yajie, Wang Wei, Wu Dongfa |
| Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO precision oncology 2022 08 6 e2100504. Wang Jennifer Rui, Montierth Matthew, Xu Li, Goswami Maitrayee, Zhao Xiao, Cote Gilbert, Wang Wenyi, Iyer Priyanka, Dadu Ramona, Busaidy Naifa L, Lai Stephen Y, Gross Neil D, Ferrarotto Renata, Lu Charles, Gunn Gary Brandon, Williams Michelle D, Routbort Mark, Zafereo Mark E, Cabanillas Maria |
| Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Ophthalmology 2022 1 129 (6): 679-693. Lally Sara E, Milman Tatyana, Orloff Marlana, Dalvin Lauren A, Eberhart Charles G, Heaphy Christopher M, Rodriguez Fausto J, Lin Chun-Chieh, Dockery Philip W, Shields Jerry A, Shields Carol |
| Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review. NPJ precision oncology 2022 4 6 (1): 27. Kaubryte Jurgita, Lai Alvina |
| PD-L1 neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab. Frontiers in immunology 2022 8 13 962669. Cristinziano Leonardo, Modestino Luca, Capone Mariaelena, Madonna Gabriele, Mallardo Domenico, Giannarelli Diana, D'Angelo Grazia, Ferrara Anne Lise, Loffredo Stefania, Varricchi Gilda, Vanella Vito, Festino Lucia, Ascierto Paolo Antonio, Galdiero Maria Rosar |
| Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma. Journal of cancer research and clinical oncology 2022 8 . Lazaridis Lazaros, Schmidt Teresa, Oster Christoph, Blau Tobias, Pierscianek Daniela, Siveke Jens T, Bauer Sebastian, Schildhaus Hans-Ulrich, Sure Ulrich, Keyvani Kathy, Kleinschnitz Christoph, Stuschke Martin, Herrmann Ken, Deuschl Cornelius, Scheffler Björn, Kebir Sied, Glas Mart |
| Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World journal of surgical oncology 2022 4 20 (1): 131. Javed Sahir, Benoist Stéphane, Devos Patrick, Truant Stéphanie, Guimbaud Rosine, Lièvre Astrid, Sefrioui David, Cohen Romain, Artru Pascal, Dupré Aurélien, Bachet Jean-Baptiste, de la Fouchardière Christelle, Ploquin Anne, Turpin Antho |
| Real-world outcomes using PD-1 antibodies and BRAF +?MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 11 . Schumann Katharina, Mauch Cornelia, Klespe Kai-Christian, Loquai Carmen, Nikfarjam Ulrike, Schlaak Max, Akçetin Larissa, Kölblinger Peter, Hoellwerth Magdalena, Meissner Markus, Mengi Guelcin, Braun Andreas Dominik, Mengoni Miriam, Dummer Reinhard, Mangana Joanna, Sindrilaru Mihaela-Anca, Radmann Dan, Hafner Christine, Freund Johann, Rappersberger Klemens, Weihsengruber Felix, Meiss Frank, Reinhardt Lydia, Meier Friedegund, Rainer Barbara, Richtig Erika, Ressler Julia Maria, Höller Christoph, Eigentler Thomas, Amaral Teresa, Peitsch Wiebke K, Hillen Uwe, Harth Wolfgang, Ziller Fabian, Schatton Kerstin, Gambichler Thilo, Susok Laura, Maul Lara Valeska, Läubli Heinz, Debus Dirk, Weishaupt Carsten, Börger Sevil, Sievers Katharina, Haferkamp Sebastian, Zenderowski Veronika, Nguyen Van Anh, Wanner Marina, Gutzmer Ralf, Terheyden Patrick, Kähler Katharina, Emmert Steffen, Thiem Alexander, Sachse Michael, Gercken-Riedel Silke, Kaune Kjell Matthias, Thoms Kai-Martin, Heinzerling Lucie, Heppt Markus Vincent, Tratzmiller Sabine, Hoetzenecker Wolfram, Öllinger Angela, Steiner Andreas, Peinhaupt Tobias, Podda Maurizio, Schmid Sabine, Wollina Uwe, Biedermann Tilo, Posch Christi |
| The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma. Neuro-oncology 2022 10 . Li Xiaoyu, Moreira Daniel C, Bag Asim K, Qaddoumi Ibrahim, Acharya Sahaja, Chiang Jas |
| A retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening. PloS one 2021 16 (10): e0244332. Sun Qing, Pastor Larry, Du Jinwei, Powell Michael J, Zhang Aiguo, Bodmer Walter, Wu Jianzhong, Zheng Shu, Sha Michael |
| Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. BMC genomics 2021 7 22 (1): 576. Lin Ruoting, Fogarty Conor E, Ma Bowei, Li Hejie, Ni Guoying, Liu Xiaosong, Yuan Jianwei, Wang Tianfa |
| Immune biomarkers and response to checkpoint inhibition of BRAF and BRAF non-V600 altered lung cancers. British journal of cancer 2021 12 126 (6): 889-898. Murciano-Goroff Yonina R, Pak Terry, Mondaca Sebastian, Flynn Jessica R, Montecalvo Joseph, Rekhtman Natasha, Halpenny Darragh, Plodkowski Andrew J, Wu Stephanie L, Kris Mark G, Paik Paul K, Riely Gregory J, Yu Helena A, Rudin Charles M, Hellmann Matthew D, Land Josiah D, Buie Larry W, Heller Glenn, Lito Piro, Yaeger Rona, Drilon Alexander, Liu Dazhi, Li Bob T, Offin Micha |
| Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study. JTO clinical and research reports 2021 9 1 (1): 100006. Zhang Chenxing, Zhang Chenyue, Lin Jiamao, Li Zhenxiang, Wang Haiyo |
| The Impact of KRAS Mutation in Patients With Sporadic Nonampullary Duodenal Epithelial Tumors. Clinical and translational gastroenterology 2021 11 12 (11): e00424. Kinugasa Hideaki, Kanzaki Hiromitsu, Tanaka Takehiro, Yamamoto Shumpei, Yamasaki Yasushi, Nouso Kazuhiro, Ichimura Kouichi, Nakagawa Masahiro, Mitsuhashi Toshiharu, Okada Hiroyu |
| TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma. Cancer immunology research 2021 8 9 (10): 1202-1213. Hodi F Stephen, Wolchok Jedd D, Schadendorf Dirk, Larkin James, Long Georgina V, Qian Xiaozhong, Saci Abdel, Young Tina C, Srinivasan Sujaya, Chang Han, Tang Hao, Wind-Rotolo Megan, Rizzo Jasmine I, Jackson Donald G, Ascierto Paolo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: